Assyro AI

Orange Book product · Brand (NDA)

SFROWASA

MESALAMINE

Brand (NDA)NDA 019618TE ABRX MYLAN SPECIALITY LP

At a glance

Jun 20, 2008

Approved

Brand (NDA)

Application

AB

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 20, 2008

    18 yr 3 mo ago

  2. Today

  3. Patent 7645801 expires

    Listed drug substance patent expiration.

    Jul 24, 2027

    in 1 yr 1 mo

Pharmaceutical detail

Active ingredient

MESALAMINE

Strength

4GM/60ML

Dosage form

ENEMA

Route

RECTAL

TE code

AB

Application

NDA 019618

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7645801Jul 24, 2027in 1 yr 1 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.